Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glecaprevir/Pibrentasvir for PTSD
NCT05637879Phase 3Recruiting
- Sponsor
- White River Junction VA Medical Center
- Start
- Dec 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glecaprevir + pibrentasvir in post-traumatic stress disorder (PTSD), sponsored by White River Junction VA Medical Center. Started Dec 2023; status: recruiting.
02
Drugs
glecaprevir + pibrentasvir
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05637879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05637879.